NFI on SKorea or US potential with other products.
Can only go on managements proven ability to execute great growth, so potential is there to use initial success in US with higher margin products on established branding.
It also works in nicely with Synlait’s plans to build a new facility in Waikato over next year or so to ramp up Infant Formula production for supply.
I’d say $16bill market cap + is well within reach by mid next year.
A2M Price at posting:
$10.97 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)